# A Study of LY3437943 in Healthy Participants With a High Body Mass Index

> **NCT05959096** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 85 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3437943
- **DRUG:** LY3437943

## Key facts

- **NCT ID:** NCT05959096
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-18
- **Primary completion:** 2024-07-25
- **Final completion:** 2024-07-25
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2024-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05959096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05959096, "A Study of LY3437943 in Healthy Participants With a High Body Mass Index". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05959096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*